David E. Goel is Director of Adaptive Biotechnologies Corp. Currently has a direct ownership of 1,504 shares of ADPT, which is worth approximately $8,302. The most recent transaction as insider was on Feb 15, 2021, when has been sold 1,504 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.5K
0% 3M change
0% 12M change
Total Value Held $8,302

DAVID E. GOEL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 15 2021
BUY
Grant, award, or other acquisition
-
1,504 Added 50.0%
1,504 Common Stock
DEG

David E. Goel

Director
Waltham, MA

Track Institutional and Insider Activities on ADPT

Follow Adaptive Biotechnologies Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADPT shares.

Notify only if

Insider Trading

Get notified when an Adaptive Biotechnologies Corp insider buys or sells ADPT shares.

Notify only if

News

Receive news related to Adaptive Biotechnologies Corp

Track Activities on ADPT